Although
perfluoroalkyl ether carboxylic (PFECAs) and sulfonic
acids (PFESAs) have been widely detected in environmental matrices,
their occurrence in humans and impact on human health remains insufficiently
understood. Here, we report on 13 PFECAs and PFESAs in 977 sera samples
collected from residents living near a fluorochemical plant in Shandong,
China. The sum concentration of these emerging PFECAs accounted for
13% of the total PFASs in the serum of the participants, with the
frequent detection of several PFECAs (>95%) (PFMOAA, PFO4DA, and
PFO5DoDA
at median concentrations of 12.91, 0.142, and 0.987 ng/mL, respectively)
and PFESAs (98.7%) (Nafion byproduct 2 at a median concentration of
0.097 ng/mL). Serum PFMOAA, PFO5DoDA, and 6:2 Cl-PFESA levels were
significantly higher in males than in females. Positive relationships
were observed between age and PFMOAA, 6:2 Cl-PFESA, and H-PFMO2OSA
levels, whereas HFPO-TA and PFO5DoDA serum concentrations in the 0–40-year
age group were lower than that in the >40-year age group. Furthermore,
multivariate linear regression models and sensitivity analyses showed
positive associations among PFO5DoDA levels, elevated lipid parameters
(cholesterol, low-density lipoprotein cholesterol, and triglycerides),
liver function markers (albumin levels and alanine transaminase, aspartate
aminotransferase, and glutamyl transpeptidase activities), and uric
acid levels. Thus, our results suggest potential health risks from
exposure to novel PFESAs and PFECAs (especially PFO5DoDA).